UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 12, 2016 (September 9, 2016)
Inspyr Therapeutics, Inc.
(Exact name of registrant as specified in Charter)
Delaware | | 0001421204 | | 20-0438951 |
(State or other jurisdiction of incorporation or organization) | | (Commission File No.) | | (IRS Employee Identification No.) |
2511 N Loop 1604 W, Suite 204
San Antonio, TX 78258
(Address of Principal Executive Offices)
210-479-8112
(Issuer Telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.02. Entry into a Material Definitive Agreement.
On September 9, 2016, Inspyr Therapeutics, Inc. (the “Company”) entered into revised indemnification agreements with its directors and officers. A copy of the form of indemnification agreement is attached hereto as Exhibit 10.01.
Item 9.01 Financial Statements and Exhibits.
| | | | |
Exhibit No. | | Description | | |
10.01 | | Form of Indemnification Agreement. | | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 12, 2016
| GenSpera, Inc. |
| | | |
| By: | | /s/ Christopher Lowe
|
| | | Christopher Lowe Chief Executive Officer |
INDEX OF EXHIBITS
| | | | |
Exhibit No. | | Description | | |
10.01 | | Form of Indemnification Agreement. | | |
| | | | |